Mycenax Biotech
Organisation
Trials
Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
Phase 1, Completed, 190 people, 11 May 2018
Phase 3, Status unknown, 91 people, 18 Oct 2012
Sources: clinicaltrials.gov
Organisation
Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
Phase 1, Completed, 190 people, 11 May 2018
Phase 3, Status unknown, 91 people, 18 Oct 2012
Sources: clinicaltrials.gov